InvestorsHub Logo
Followers 30
Posts 2500
Boards Moderated 0
Alias Born 07/28/2005

Re: ststephensrevenge post# 309739

Thursday, 08/24/2017 3:27:12 PM

Thursday, August 24, 2017 3:27:12 PM

Post# of 345890
St stephens... BOD compensation is an issue in and of itself, that received the attention of the two share holders who brought suit against PPHM a couple years ago and negotiated the settlement agreement with PPHM on behalf of all PPHM shareholders in advance of the July 27 hearing. Your dissatisfaction with what they negotiated might be well supported, but all the PPHM shareholders need to recognize that the pair brought the Settlement Agreement before the Delaware Chancery Court in a manner that pretty much usurps all other share holders' opinions about how they should have settled with other terms, since opportunity was given to challenge, augment or redefine the Settlement Agreement terms before the Delaware Court. I received the legal notice at my home mailbox, with what appeared to be too little notice for me to consider going to the Delaware hearing, but I did receive a notification and would not have gone anyway (too far). Like it or not, the Delaware Chancery Court hearing settled what was deemed acceptable to both PPHM shareholders and PPHM Board members for Board compensation, described in the terms of the settlement agreement.

I observe the PPHM Board compensation issue has been getting postured by some as a diversion of attention away from the Ronin, PPHM take over attempt in process. It is also noteworthy that the Delaware Chancery court judge make a statement that he was outlining his observations and views about the compensation decisions made by the PPHM Board for the purpose of helping educate those involved with the questionable compensation measures brought before the Court. I hope the claw back of $1.5 million, the cut in annual compensation to a limit of 75% of peer Pharma Director compensation and the judge's explanation of what was wrong with the previous decision making makes for a sufficient lesson learned for the existing PPHM BOD. We shall see.

Now, what is Ronin doing to provide assurances to long investors that long investors won't get disenfranchised from the value of PPHM proprietary technology under Ronin's proposed Board leadership?

Best wishes and IMO.
KT
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News